Detailed information for compound 165772

Basic information

Technical information
  • TDR Targets ID: 165772
  • Name: 1-[2-[2-[benzyl(methyl)amino]ethoxy]ethyl]-3- (4-chlorophenyl)thiourea
  • MW: 377.931 | Formula: C19H24ClN3OS
  • H donors: 2 H acceptors: 0 LogP: 3.54 Rotable bonds: 11
    Rule of 5 violations (Lipinski): 1
  • SMILES: CN(Cc1ccccc1)CCOCCNC(=S)Nc1ccc(cc1)Cl
  • InChi: 1S/C19H24ClN3OS/c1-23(15-16-5-3-2-4-6-16)12-14-24-13-11-21-19(25)22-18-9-7-17(20)8-10-18/h2-10H,11-15H2,1H3,(H2,21,22,25)
  • InChiKey: YXIDPUJWSXNQBE-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 1-(4-chlorophenyl)-3-[2-[2-[methyl(phenylmethyl)amino]ethoxy]ethyl]thiourea
  • 3-(4-chlorophenyl)-1-[2-[2-(methyl-(phenylmethyl)amino)ethoxy]ethyl]thiourea
  • 1-[2-[2-(benzyl-methyl-amino)ethoxy]ethyl]-3-(4-chlorophenyl)thiourea

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Rattus norvegicus Acetylcholinesterase Starlite/ChEMBL References
Homo sapiens acetylcholinesterase (Yt blood group) Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Schistosoma japonicum ko:K01049 acetylcholinesterase [EC3.1.1.7], putative Get druggable targets OG5_126875 All targets in OG5_126875
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_126875 All targets in OG5_126875
Schistosoma japonicum Acetylcholinesterase 1 precursor, putative Get druggable targets OG5_126875 All targets in OG5_126875
Loa Loa (eye worm) carboxylesterase Get druggable targets OG5_126875 All targets in OG5_126875
Echinococcus granulosus acetylcholinesterase Get druggable targets OG5_126875 All targets in OG5_126875
Echinococcus granulosus carboxylesterase 5A Get druggable targets OG5_126875 All targets in OG5_126875
Brugia malayi Carboxylesterase family protein Get druggable targets OG5_126875 All targets in OG5_126875
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_126875 All targets in OG5_126875
Echinococcus multilocularis acetylcholinesterase Get druggable targets OG5_126875 All targets in OG5_126875
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) Get druggable targets OG5_126875 All targets in OG5_126875
Loa Loa (eye worm) acetylcholinesterase 1 Get druggable targets OG5_126875 All targets in OG5_126875
Echinococcus granulosus acetylcholinesterase Get druggable targets OG5_126875 All targets in OG5_126875
Brugia malayi Carboxylesterase family protein Get druggable targets OG5_126875 All targets in OG5_126875
Echinococcus multilocularis carboxylesterase 5A Get druggable targets OG5_126875 All targets in OG5_126875
Echinococcus multilocularis acetylcholinesterase Get druggable targets OG5_126875 All targets in OG5_126875

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Brugia malayi Carboxylesterase family protein acetylcholinesterase (Yt blood group) 614 aa 510 aa 26.5 %
Onchocerca volvulus Molybdopterin synthase catalytic subunit homolog Acetylcholinesterase   614 aa 564 aa 29.8 %
Echinococcus multilocularis BC026374 protein (S09 family) Acetylcholinesterase   614 aa 642 aa 34.0 %
Drosophila melanogaster CG10175 gene product from transcript CG10175-RE Acetylcholinesterase   614 aa 547 aa 32.5 %
Echinococcus granulosus BC026374 protein S09 family Acetylcholinesterase   614 aa 642 aa 34.1 %
Onchocerca volvulus Carnitine O-palmitoyltransferase 2, mitochondrial homolog Acetylcholinesterase   614 aa 531 aa 39.7 %
Echinococcus multilocularis neuroligin Acetylcholinesterase   614 aa 496 aa 24.0 %
Brugia malayi Carboxylesterase family protein Acetylcholinesterase   614 aa 507 aa 26.4 %
Loa Loa (eye worm) hypothetical protein Acetylcholinesterase   614 aa 570 aa 25.4 %
Brugia malayi Carboxylesterase family protein Acetylcholinesterase   614 aa 573 aa 30.5 %
Onchocerca volvulus Putative nuclear protein Acetylcholinesterase   614 aa 577 aa 40.7 %
Onchocerca volvulus Acetylcholinesterase   614 aa 581 aa 27.0 %
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) Acetylcholinesterase   614 aa 602 aa 24.3 %
Onchocerca volvulus Acetylcholinesterase   614 aa 583 aa 30.7 %
Onchocerca volvulus Acetylcholinesterase   614 aa 632 aa 25.6 %
Loa Loa (eye worm) hypothetical protein Acetylcholinesterase   614 aa 574 aa 24.0 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus granulosus NADPH cytochrome P450 reductase 0.1514 1 1
Trypanosoma cruzi NADPH-dependent FMN/FAD containing oxidoreductase, putative 0.1514 1 1
Loa Loa (eye worm) FAD binding domain-containing protein 0.0935 0.3805 0.3805
Trichomonas vaginalis NADPH fad oxidoreductase, putative 0.1342 0.8159 0.8159
Leishmania major p450 reductase, putative 0.1514 1 1
Brugia malayi FAD binding domain containing protein 0.1514 1 1
Toxoplasma gondii flavodoxin domain-containing protein 0.0751 0.1841 0.5
Leishmania major cytochrome P450 reductase, putative 0.1342 0.8159 0.8159
Chlamydia trachomatis sulfite reductase 0.0935 0.3805 0.5
Trypanosoma cruzi cytochrome P450 reductase, putative 0.1514 1 1
Plasmodium vivax NADPH-cytochrome p450 reductase, putative 0.1514 1 1
Plasmodium vivax flavodoxin domain containing protein 0.1342 0.8159 0.8159
Schistosoma mansoni 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase 0.0935 0.3805 0.2407
Trypanosoma cruzi p450 reductase, putative 0.1514 1 1
Entamoeba histolytica type A flavoprotein, putative 0.0579 0 0.5
Trichomonas vaginalis sulfite reductase, putative 0.1514 1 1
Entamoeba histolytica type A flavoprotein, putative 0.0579 0 0.5
Trypanosoma brucei NADPH-dependent diflavin oxidoreductase 1 0.1514 1 1
Brugia malayi FAD binding domain containing protein 0.0935 0.3805 0.3805
Giardia lamblia Nitric oxide synthase, inducible 0.1342 0.8159 0.5
Trypanosoma brucei NADPH-cytochrome p450 reductase, putative 0.1514 1 1
Echinococcus granulosus NADPH dependent diflavin oxidoreductase 1 0.1514 1 1
Echinococcus multilocularis NADPH cytochrome P450 reductase 0.1514 1 1
Trypanosoma brucei NADPH--cytochrome P450 reductase, putative 0.1514 1 1
Plasmodium falciparum nitric oxide synthase, putative 0.1514 1 1
Loa Loa (eye worm) FAD binding domain-containing protein 0.1514 1 1
Entamoeba histolytica type A flavoprotein, putative 0.0579 0 0.5
Schistosoma mansoni cytochrome P450 reductase 0.1514 1 1
Giardia lamblia Hypothetical protein 0.1342 0.8159 0.5
Schistosoma mansoni NADPH flavin oxidoreductase 0.0763 0.1964 0.0151
Entamoeba histolytica type A flavoprotein, putative 0.0579 0 0.5
Entamoeba histolytica type A flavoprotein, putative 0.0579 0 0.5
Echinococcus multilocularis NADPH dependent diflavin oxidoreductase 1 0.1514 1 1
Toxoplasma gondii flavodoxin domain-containing protein 0.0751 0.1841 0.5
Leishmania major NADPH-cytochrome p450 reductase-like protein 0.1514 1 1
Loa Loa (eye worm) hypothetical protein 0.1514 1 1
Treponema pallidum flavodoxin 0.0579 0 0.5
Mycobacterium ulcerans formate dehydrogenase H FdhF 0.1514 1 0.5
Trypanosoma cruzi cytochrome P450 reductase, putative 0.1514 1 1
Trypanosoma brucei NADPH--cytochrome P450 reductase, putative 0.1514 1 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 1800 nM In vitro inhibitory effect on rat Acetylcholinesterase ChEMBL. 7636858
IC50 (binding) = 1800 nM In vitro inhibitory effect on rat Acetylcholinesterase ChEMBL. 7636858
IC50 (binding) = 1800 nM Inhibition of AChE ChEMBL. 20053484

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

2 literature references were collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.